Mizuho Raises PT on ICON Public Limited Company (ICLR) to $225; Maintains 'Outperform' Rating

With a low price-to-earnings multiple and a significant presence in Seth Klarman’s investment portfolio, ICON Public Limited Company (NASDAQ:ICLR) earns a spot on our list of the 12 Cheap Value Stocks to Buy Now According to Seth Klarman.

On July 25, 2025, Mizuho raised its price target on ICON Public Limited Company (NASDAQ:ICLR) from $173 to $225, maintaining an ‘Outperform’ rating. The price revision is attributed to the company’s stronger-than-expected operational metrics. Eliminating earlier fears of a slowdown, its quarterly booking trends remained stable. Furthermore, improved cancellation rates and easing trial delays boosted confidence in the company’s execution.

Moreover, the analyst feels enhanced earnings visibility for 2026 for ICON Public Limited Company (NASDAQ:ICLR), indicating a stronger growth trajectory, in spite of macro uncertainties in the clinical research market. Thus, the analyst’s price revision reflects both the short-term momentum and long-term strategic positioning, increasing the possibility of the company capturing a larger share of clinical trial demand in the coming years.

ICON Public Limited Company (NASDAQ:ICLR) executes clinical research globally, offering outsourced development and commercialization services. It is included in our list of cheap value stocks to buy.

While we acknowledge the potential of ICLR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best AI Stocks to Buy Under $3 and Bill Ackman Stock Portfolio: Top 10 Stock Picks.

Disclosure: None.